These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29942043)

  • 1. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
    Mick I; Myers J; Ramos AC; Stokes PR; Erritzoe D; Colasanti A; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Galduróz JC; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
    Neuropsychopharmacology; 2016 Jun; 41(7):1742-50. PubMed ID: 26552847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.
    Ghitza UE; Preston KL; Epstein DH; Kuwabara H; Endres CJ; Bencherif B; Boyd SJ; Copersino ML; Frost JJ; Gorelick DA
    Biol Psychiatry; 2010 Oct; 68(8):697-703. PubMed ID: 20579973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
    Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
    Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute acetate administration increases endogenous opioid levels in the human brain: A [
    Ashok AH; Myers J; Frost G; Turton S; Gunn RN; Passchier J; Colasanti A; Marques TR; Nutt D; Lingford-Hughes A; Howes OD; Rabiner EA
    J Psychopharmacol; 2021 May; 35(5):606-610. PubMed ID: 33406950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
    Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
    Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.
    Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; Reed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA
    Biol Psychiatry; 2012 Sep; 72(5):371-7. PubMed ID: 22386378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.
    Mick I; Myers J; Stokes PR; Erritzoe D; Colasanti A; Bowden-Jones H; Clark L; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Nutt DJ; Lingford-Hughes AR
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2069-74. PubMed ID: 24807268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino ML; Dannals RF; Frost JJ
    Psychopharmacology (Berl); 2008 Nov; 200(4):475-86. PubMed ID: 18762918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.
    Spreckelmeyer KN; Paulzen M; Raptis M; Baltus T; Schaffrath S; Van Waesberghe J; Zalewski MM; Rösch F; Vernaleken I; Schäfer WM; Gründer G
    Biol Psychiatry; 2011 Oct; 70(8):770-776. PubMed ID: 21802658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.
    Saanijoki T; Nummenmaa L; Tuulari JJ; Tuominen L; Arponen E; Kalliokoski KK; Hirvonen J
    Hum Brain Mapp; 2018 Oct; 39(10):3972-3983. PubMed ID: 29885086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
    Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
    PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies.
    Hansson AC; Gründer G; Hirth N; Noori HR; Spanagel R; Sommer WH
    Neurosci Biobehav Rev; 2019 Nov; 106():141-164. PubMed ID: 30243576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.